Clinical trial
Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in…
NCT00438984 · Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Other · Completed
Key facts
| NCT number | NCT00438984 |
|---|---|
| Title | Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma |
| Official title | Phase I Study To Evaluate Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cell Clones Following Cyclophosphamide Conditioning For Patients With Metastatic Melanoma |
| Lead sponsor | Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Recurrent Melanoma, Stage IV Melanoma |
| Intervention type | Biological, Drug, Genetic, Other, Procedure |
| Interventions | cyclophosphamide, therapeutic autologous lymphocytes, aldesleukin, immunohistochemistry staining method, biopsy, laboratory biomarker analysis, immunologic technique, polymerase chain reaction |
| Enrollment | 11 |
| Start date | Dec 1, 2006 |
| Primary completion | Jan 1, 2011 |
| Completion | Feb 1, 2012 |
| First posted | Feb 22, 2007 |
| Last update posted | Mar 16, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: